Chemed Corporation (CHE)

New York Stock Exchange:
CHE
| Latest update: Feb 23, 2026, 6:29 PM

Stock events for Chemed Corp. (CHE)

Chemed's stock experienced fluctuations with an all-time high of $646.13 on March 19, 2024. Analyst reports in late 2025 and early 2026 varied, with some downgrades and price objective reductions. In July 2025, Chemed reported a revenue increase of 3.8% but a decrease in GAAP and adjusted diluted EPS. The company authorized an additional $300 million for stock repurchase in Q2 2025. A negative update on full-year 2025 guidance was issued due to projected Medicare Cap revenue limitations for VITAS in Florida.

Demand Seasonality affecting Chemed Corp.’s stock price

Demand seasonality for Chemed's products and services is influenced by external factors. VITAS experienced unexpected weakness in admissions in April and May 2025. Roto-Rooter saw a decline in residential demand in the second quarter of 2025, partially offset by commercial demand. The company's 2025 earnings trajectory is weighted towards the second half of the year.

Overview of Chemed Corp.’s business

Chemed Corp. is a diversified holding company operating in healthcare and industrial services through VITAS Healthcare and Roto-Rooter. VITAS Healthcare provides end-of-life hospice and palliative care services. Roto-Rooter offers plumbing, drain cleaning, and water restoration services. In 2024, Chemed reported revenues of $2.43 billion, a 7.37% increase, and earnings of $302.00 million, a 10.82% increase.

CHE’s Geographic footprint

VITAS Healthcare operates 56 hospice programs across 15 states and the District of Columbia. Roto-Rooter provides services across the United States and Canada, with licensed master franchisees in Indonesia, Singapore, and the Philippines.

CHE Corporate Image Assessment

Chemed Corporation has a reputation for reliability and expertise. VITAS Healthcare is recognized as a provider of end-of-life care services. Roto-Rooter is known for plumbing, drain cleaning, and water cleanup services. Concerns have been raised regarding VITAS's profitability due to Medicare Cap revenue limitations and weaker admissions. Roto-Rooter faced unexpected weakness in residential demand for plumbing services.

Ownership

Institutional investors are the primary owners of Chemed Corporation, including Vanguard Group Inc., BlackRock, Inc., and Kayne Anderson Rudnick Investment Management Llc. CEO Kevin McNamara also holds a notable insider stake.

Expert AI

Show me the sentiment for Chemed Corp.
What's the latest sentiment for Chemed Corp.?

Price Chart

$479.49

0.86%
(1 month)

Top Shareholders

The Vanguard Group, Inc.
10.40%
BlackRock, Inc.
9.08%
The Toronto-Dominion Bank
4.58%
JPMorgan Chase & Co.
3.68%
Virtus Investment Partners, Inc.
3.29%
State Street Corp.
3.23%
NBSH Acquisition LLC
2.91%
Geode Holdings Trust
2.53%

Trade Ideas for CHE

Today

Sentiment for CHE

News
Social

Buzz Talk for CHE

Today

Social Media

FAQ

What is the current stock price of Chemed Corp.?

As of the latest update, Chemed Corp.'s stock is trading at $479.49 per share.

What’s happening with Chemed Corp. stock today?

Today, Chemed Corp. stock is up by 0.86%, possibly due to news.

What is the market sentiment around Chemed Corp. stock?

Current sentiment around Chemed Corp. stock is positive, based on recent news, trading volume, and analyst opinions.

Is Chemed Corp.'s stock price growing?

Over the past month, Chemed Corp.'s stock price has increased by 0.86%.

How can I buy Chemed Corp. stock?

You can buy Chemed Corp. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol CHE

Who are the major shareholders of Chemed Corp. stock?

Major shareholders of Chemed Corp. include institutions such as The Vanguard Group, Inc. (10.40%), BlackRock, Inc. (9.08%), The Toronto-Dominion Bank (4.58%) ... , according to the latest filings.